BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9815593)

  • 41. Changes in gene expression profile in two multidrug resistant cell lines derived from a same drug sensitive cell line.
    Moreira MA; Bagni C; de Pinho MB; Mac-Cormick TM; dos Santos Mota M; Pinto-Silva FE; Daflon-Yunes N; Rumjanek VM
    Leuk Res; 2014 Aug; 38(8):983-7. PubMed ID: 24996974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amplification of the murine mdr2 gene and a reconsideration of the structure of the murine mdr gene locus.
    Kirschner LS
    DNA Cell Biol; 1995 Jan; 14(1):47-59. PubMed ID: 7832992
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Accurate monitoring of promoter gene methylation with high-resolution melting polymerase chain reaction using the ABCB1 gene as a model.
    Mencalha AL; Rodrigues EF; Abdelhay E; Fernandez TS
    Genet Mol Res; 2013 Mar; 12(1):714-22. PubMed ID: 23546954
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line.
    Hu XF; Slater A; Wall DM; Kantharidis P; Parkin JD; Cowman A; Zalcberg JR
    Br J Cancer; 1995 May; 71(5):931-6. PubMed ID: 7734315
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The potential of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide to circumvent three multidrug-resistance phenotypes in vitro.
    Davey RA; Su GM; Hargrave RM; Harvie RM; Baguley BC; Davey MW
    Cancer Chemother Pharmacol; 1997; 39(5):424-30. PubMed ID: 9054956
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias.
    Nakayama M; Wada M; Harada T; Nagayama J; Kusaba H; Ohshima K; Kozuru M; Komatsu H; Ueda R; Kuwano M
    Blood; 1998 Dec; 92(11):4296-307. PubMed ID: 9834236
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methylation of SFRP5 is related to multidrug resistance in leukemia cells.
    Wang H; Wang X; Hu R; Yang W; Liao A; Zhao C; Zhang J; Liu Z
    Cancer Gene Ther; 2014 Feb; 21(2):83-9. PubMed ID: 24434572
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Demethylation of the human MDR1 5' region accompanies activation of P-glycoprotein expression in a HL60 multidrug resistant subline.
    Desiderato L; Davey MW; Piper AA
    Somat Cell Mol Genet; 1997 Nov; 23(6):391-400. PubMed ID: 9661702
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The multidrug resistance phenotype confers immunological resistance.
    Weisburg JH; Curcio M; Caron PC; Raghu G; Mechetner EB; Roepe PD; Scheinberg DA
    J Exp Med; 1996 Jun; 183(6):2699-704. PubMed ID: 8676093
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine.
    Herweijer H; Sonneveld P; Baas F; Nooter K
    J Natl Cancer Inst; 1990 Jul; 82(13):1133-40. PubMed ID: 1972761
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methylation analysis of the human multidrug resistance 1 gene in normal and leukemic hematopoietic cells.
    Fryxell KB; McGee SB; Simoneaux DK; Willman CL; Cornwell MM
    Leukemia; 1999 Jun; 13(6):910-7. PubMed ID: 10360380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Involvement of MDR1 P-glycoprotein in multifactorial resistance to methotrexate.
    Norris MD; De Graaf D; Haber M; Kavallaris M; Madafiglio J; Gilbert J; Kwan E; Stewart BW; Mechetner EB; Gudkov AV; Roninson IB
    Int J Cancer; 1996 Mar; 65(5):613-9. PubMed ID: 8598312
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multidrug resistance in lymphomas.
    Yuen AR; Sikic BI
    J Clin Oncol; 1994 Nov; 12(11):2453-9. PubMed ID: 7964963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of an mdr gene is associated with a new form of resistance to dexamethasone-induced apoptosis.
    Bourgeois S; Gruol DJ; Newby RF; Rajah FM
    Mol Endocrinol; 1993 Jul; 7(7):840-51. PubMed ID: 8105374
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Analysis of methylation status of the promoter of mdr1 gene in K562 and K562/DNR cells].
    Gao F; Zhang JD; Liu YP; Lu XL
    Zhonghua Xue Ye Xue Za Zhi; 2004 May; 25(5):293-5. PubMed ID: 15182540
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Methylation status of multidrug resistance (mdr1) gene and its correlation with expression of mdr1 gene in patients with hematologic malignancies].
    Zhu Y; Wu SL; Bu DF; Li Y; Zhu Q; Cao XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Feb; 12(1):6-10. PubMed ID: 14989760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure of the human MDR3 gene and physical mapping of the human MDR locus.
    Lincke CR; Smit JJ; van der Velde-Koerts T; Borst P
    J Biol Chem; 1991 Mar; 266(8):5303-10. PubMed ID: 2002063
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of verapamil on daunorubicin accumulation in human leukemic cells with different levels of MDR1 gene expression.
    Gruber A; Briese B; Areström I; Vitols S; Björkholm M; Peterson C
    Leuk Res; 1993 Apr; 17(4):353-8. PubMed ID: 8487584
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation exerted by miRNAs in the promoter and UTR sequences: MDR1/P-gp expression as a particular case.
    Toscano-Garibay JD; Aquino-Jarquin G
    DNA Cell Biol; 2012 Aug; 31(8):1358-64. PubMed ID: 22662865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential effects of the MDR1 (multidrug resistance) gene-activating agents on protein kinase C: evidence for redundancy of mechanisms of acquired MDR in leukemia cells.
    Shtil AA; Ktitorova OV; Kakpakova ES; Holian O
    Leuk Lymphoma; 2000 Dec; 40(1-2):191-5. PubMed ID: 11426620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.